Journal
CARDIORENAL MEDICINE
Volume 12, Issue 5-6, Pages 229-235Publisher
KARGER
DOI: 10.1159/000525448
Keywords
Sudden cardiac death; Genetics; Cardiovascular disease; Dialysis
Funding
- NIH
- AMGEN
- [R01DK100306]
Ask authors/readers for more resources
The G3 variant in the APOL1 gene was found to be associated with cardiovascular mortality and sudden cardiac death in European ancestry patients receiving dialysis. Validation studies using ICD codes in the Vanderbilt BioVU also confirmed associations between cardiovascular events and cardiovascular mortality in EA participants.
Introduction: The G1 and G2 variants in the APOL1 gene convey high risk for the progression of chronic kidney disease in African Americans. The G3 variant in APOL1 is more common in patients of European ancestry (EA); outcomes associated with this variant have not been explored previously in EA patients receiving dialysis. Methods: DNA was collected from approximately half of the patients enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial and genotyped for the G3 variants. We utilized an additive genetic model to test associations of G3 with the EVOLVE adjudicated endpoints of all-cause mortality, cardiovascular mortality, sudden cardiac death (SCD), and heart failure. EA and African ancestry samples were analyzed separately. Validation was done in the Vanderbilt BioVU using ICD codes for cardiovascular events that parallel the adjudicated endpoints in EVOLVE. Results: In EVOLVE, G3 in EA patients was associated with the adjudicated endpoints of cardiovascular mortality and SCD. In a validation cohort from the Vanderbilt BioVU, cardiovascular events and cardiovascular mortality defined by ICD codes showed similar associations in EA participants who had been on dialysis for 2 to Discussion/Conclusions: G3 in APOL1 variant was associated with cardiovascular events and cardiovascular mortality in the EA patients receiving dialysis. This suggests that variations in the APOL1 gene that differ in populations of different ancestry may contribute to cardiovascular disease. (C) 2022 The Author(s). Published by S. Karger AG, Basel
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available